Company / PP&E (Net)
BICYCLE THERAPEUTICS PLC PP&E (Net) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$6.0M
FY2025
5-year range
$3.1M / $19.1M
FY2021-FY2025
Trend
-36.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) has declined for 3 consecutive years, from $19M in FY2022 to $6M in FY2025.
Based on SEC 10-K filings.
$6M in FY2025 with a 5-year CAGR of +21.0%.
Declined from $15M to $6M over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -32.0%
- 5-Year CAGR
- +21.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- BICYCLE THERAPEUTICS PLC's pp&e (net) has declined for 3 consecutive years.
- 5-year CAGR of +21.0%, indicating consistent growth.
- In FY2025, pp&e (net) decreased 36.7% year-over-year.
- Peak pp&e (net) was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.98 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.0M | -36.7% |
| FY2024 | $9.5M | -34.4% |
| FY2023 | $14.5M | -24.0% |
| FY2022 | $19.1M | +511.9% |
| FY2021 | $3.1M | +34.8% |
| FY2020 | $2.3M | +1.1% |
| FY2019 | $2.3M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026